{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:02:21Z","timestamp":1787889741999,"version":"build-2784847793"},"reference-count":123,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.nut.2024.112610","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T15:54:35Z","timestamp":1729698875000},"page":"112610","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Plant-derived compounds as potential neuroprotective agents in Parkinson's disease"],"prefix":"10.1016","volume":"130","author":[{"given":"Chengu","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaoxian","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingcai","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nut.2024.112610_bib0001","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1159\/000517750","article-title":"Epidemiology of Parkinson's disease in Chile","volume":"55","author":"Vial","year":"2021","journal-title":"Neuroepidemiology"},{"issue":"4","key":"10.1016\/j.nut.2024.112610_bib0002","doi-asserted-by":"crossref","first-page":"e22720","DOI":"10.1002\/jbt.22720","article-title":"Neuroprotective potential of cinnamon and its metabolites in Parkinson's disease: mechanistic insights, limitations, and novel therapeutic opportunities","volume":"35","author":"Angelopoulou","year":"2021","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1016\/j.nut.2024.112610_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2022.113091","article-title":"Curcumin can improve Parkinson's disease via activating BDNF\/PI3k\/Akt signaling pathways","volume":"164","author":"Jin","year":"2022","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.nut.2024.112610_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.971298","article-title":"DNA methylation as a mediator of genetic and environmental influences on Parkinson's disease susceptibility: impacts of alpha-Synuclein, physical activity, and pesticide exposure on the epigenome","volume":"13","author":"Schaffner","year":"2022","journal-title":"Front Genet"},{"issue":"6","key":"10.1016\/j.nut.2024.112610_bib0005","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/jnc.15154","article-title":"The multi-faceted role of mitochondria in the pathology of Parkinson's disease","volume":"156","author":"Trinh","year":"2021","journal-title":"J Neurochem"},{"issue":"15","key":"10.1016\/j.nut.2024.112610_bib0006","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1021\/acschemneuro.1c00206","article-title":"Evolving role of natural products from traditional medicinal herbs in the treatment of Alzheimer's disease","volume":"12","author":"Pandey","year":"2021","journal-title":"ACS Chem Neurosci"},{"issue":"4","key":"10.1016\/j.nut.2024.112610_bib0007","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s11418-021-01545-7","article-title":"Phytochemical studies on traditional herbal medicines based on the ethnopharmacological information obtained by field studies","volume":"75","author":"Tanaka","year":"2021","journal-title":"J Nat Med"},{"key":"10.1016\/j.nut.2024.112610_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115753","article-title":"Phytoconstituents of Datura metel extract improved motor coordination in haloperidol-induced cataleptic mice: dual-target molecular docking and behavioural studies","volume":"300","author":"Lawal","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.nut.2024.112610_bib0009","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6680935","article-title":"Natural phytochemicals as novel therapeutic strategies to prevent and treat Parkinson's disease: current knowledge and future perspectives","volume":"2021","author":"Balakrishnan","year":"2021","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"10.1016\/j.nut.2024.112610_bib0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/1566524022666211222161637","article-title":"Free radicals and oxidative stress: signaling mechanisms, redox basis for human diseases, and cell cycle regulation","volume":"23","author":"Sadiq","year":"2023","journal-title":"Curr Mol Med"},{"issue":"2","key":"10.1016\/j.nut.2024.112610_bib0011","doi-asserted-by":"crossref","first-page":"e22735","DOI":"10.1096\/fj.202200278RR","article-title":"Cannabidivarin alleviates \u03b1-synuclein aggregation via DAF-16 in caenorhabditis elegans","volume":"37","author":"Wang","year":"2023","journal-title":"FASEB J"},{"issue":"10","key":"10.1016\/j.nut.2024.112610_bib0012","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3390\/antiox9101020","article-title":"Mitochondrial dysfunction, oxidative stress and neuroinflammation in neurodegeneration with brain iron accumulation (NBIA)","volume":"9","author":"Hinarejos","year":"2020","journal-title":"Antioxidants (Basel)"},{"issue":"4","key":"10.1016\/j.nut.2024.112610_bib0013","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41419-020-2454-8","article-title":"Transient receptor potential ion channel TRPM2 promotes AML proliferation and survival through modulation of mitochondrial function, ROS, and autophagy","volume":"11","author":"Chen","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.nut.2024.112610_bib0014","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neuroscience.2022.07.034","article-title":"Oxidative stress inhibition via apocynin prevents medullary respiratory neurodegeneration and respiratory pattern dysfunction in a 6-hydroxydopamine animal model of Parkinson's disease","volume":"502","author":"Nascimento","year":"2022","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.nut.2024.112610_bib0015","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1038\/s41418-020-00688-6","article-title":"Activating transcription factor-4 promotes neuronal death induced by Parkinson's disease neurotoxins and alpha-synuclein aggregates","volume":"28","author":"Demmings","year":"2021","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.nut.2024.112610_bib0016","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1743-0003-2-20","article-title":"Gait dynamics in mouse models of Parkinson's disease and Huntington's disease","volume":"2","author":"Amende","year":"2005","journal-title":"J Neuroeng Rehabil"},{"issue":"3","key":"10.1016\/j.nut.2024.112610_bib0017","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/acn3.51512","article-title":"Characteristics of systemic inflammation and brain iron deposition in Parkinson's disease patients","volume":"9","author":"Xu","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.nut.2024.112610_bib0018","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.09.012","article-title":"Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease","volume":"155","author":"Zucca","year":"2017","journal-title":"Prog Neurobiol"},{"issue":"11","key":"10.1016\/j.nut.2024.112610_bib0019","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3390\/antiox9111159","article-title":"Dopamine therapy and the regulation of oxidative stress and mitochondrial DNA copy number in patients with Parkinson's disease","volume":"9","author":"Chen","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.nut.2024.112610_bib0020","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.parkreldis.2018.01.003","article-title":"NADPH oxidases 2 activation in patients with Parkinson's disease","volume":"49","author":"Marrali","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.nut.2024.112610_bib0021","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.redox.2017.02.016","article-title":"NADPH oxidase-derived H(2)O(2) mediates the regulatory effects of microglia on astrogliosis in experimental models of Parkinson's disease","volume":"12","author":"Hou","year":"2017","journal-title":"Redox Biol"},{"key":"10.1016\/j.nut.2024.112610_bib0022","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1742-2094-4-23","article-title":"Sinomenine, a natural dextrorotatory morphinan analog, is anti-inflammatory and neuroprotective through inhibition of microglial NADPH oxidase","volume":"4","author":"Qian","year":"2007","journal-title":"J Neuroinflammation"},{"issue":"1","key":"10.1016\/j.nut.2024.112610_bib0023","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/cbin.10864","article-title":"SIRT1 mediates salidroside-elicited protective effects against MPP(+) -induced apoptosis and oxidative stress in SH-SY5Y cells: involvement in suppressing MAPK pathways","volume":"42","author":"Wang","year":"2018","journal-title":"Cell Biol Int"},{"issue":"1-2","key":"10.1016\/j.nut.2024.112610_bib0024","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jns.2014.11.026","article-title":"Tanshinone IIA prevents the loss of nigrostriatal dopaminergic neurons by inhibiting NADPH oxidase and iNOS in the MPTP model of Parkinson's disease","volume":"348","author":"Ren","year":"2015","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nut.2024.112610_bib0025","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.biopha.2018.07.095","article-title":"Therapeutic effects of honokiol on motor impairment in hemiparkinsonian mice are associated with reversing neurodegeneration and targeting PPAR\u03b3 regulation","volume":"108","author":"Chen","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"10.1016\/j.nut.2024.112610_bib0026","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1345\/aph.1G271","article-title":"Vitamin E. supplementation in Alzheimer's disease, Parkinson's disease, tardive dyskinesia, and cataract: Part 2","volume":"39","author":"Pham","year":"2005","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.nut.2024.112610_bib0027","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1468-1331.2010.03088.x","article-title":"Dietary intake of antioxidant vitamins and risk of Parkinson's disease: a case-control study in Japan","volume":"18","author":"Miyake","year":"2011","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nut.2024.112610_bib0028","article-title":"Evaluating dose- and time-dependent effects of vitamin C treatment on a Parkinson's disease fly model","volume":"2019","author":"Man Anh","year":"2019","journal-title":"Parkinsons Dis"},{"issue":"6","key":"10.1016\/j.nut.2024.112610_bib0029","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S1474-4422(05)70097-1","article-title":"Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis","volume":"4","author":"Etminan","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nut.2024.112610_bib0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s42466-019-0033-1","article-title":"An omics-based strategy using coenzyme Q10 in patients with Parkinson's disease: concept evaluation in a double-blind randomized placebo-controlled parallel group trial","volume":"1","author":"Prasuhn","year":"2019","journal-title":"Neurol Res Pract"},{"issue":"3","key":"10.1016\/j.nut.2024.112610_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173503","article-title":"Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging","volume":"12","author":"Weng","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.nut.2024.112610_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118853","article-title":"Astragaloside IV-induced Nrf2 nuclear translocation ameliorates lead-related cognitive impairments in mice","volume":"1868","author":"Yu","year":"2021","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"7","key":"10.1016\/j.nut.2024.112610_bib0033","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00109-021-02071-5","article-title":"Nrf2 as a potential target for Parkinson's disease therapy","volume":"99","author":"Niu","year":"2021","journal-title":"J Mol Med (Berl)"},{"issue":"4","key":"10.1016\/j.nut.2024.112610_bib0034","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1021\/acs.jafc.7b04641","article-title":"Comparison of adaptive neuroprotective mechanisms of sulforaphane and its interconversion product erucin in in vitro and in vivo models of Parkinson's disease","volume":"66","author":"Morroni","year":"2018","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.nut.2024.112610_bib0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.brainres.2017.02.021","article-title":"Ellagic acid exerts protective effect in intrastriatal 6-hydroxydopamine rat model of Parkinson's disease: Possible involvement of ERbeta\/Nrf2\/HO-1 signaling","volume":"1662","author":"Baluchnejadmojarad","year":"2017","journal-title":"Brain Res"},{"key":"10.1016\/j.nut.2024.112610_bib0036","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cbi.2016.03.023","article-title":"Modulatory effects of resveratrol on endoplasmic reticulum stress-associated apoptosis and oxido-inflammatory markers in a rat model of rotenone-induced Parkinson's disease","volume":"251","author":"Gaballah","year":"2016","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.nut.2024.112610_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111644","article-title":"Puerarin suppresses MPP(+)\/MPTP-induced oxidative stress through an Nrf2-dependent mechanism","volume":"144","author":"Li","year":"2020","journal-title":"Food Chem Toxicol"},{"issue":"7","key":"10.1016\/j.nut.2024.112610_bib0038","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1007\/s12035-020-01934-1","article-title":"Ferulic acid ameliorates MPP(+)\/MPTP-induced oxidative stress via ERK1\/2-dependent Nrf2 activation: translational implications for Parkinson disease treatment","volume":"57","author":"Li","year":"2020","journal-title":"Mol Neurobiol"},{"issue":"2","key":"10.1016\/j.nut.2024.112610_bib0039","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.lfs.2014.08.004","article-title":"Gastrodin prevents motor deficits and oxidative stress in the MPTP mouse model of Parkinson's disease: involvement of ERK1\/2-Nrf2 signaling pathway","volume":"114","author":"Wang","year":"2014","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.nut.2024.112610_bib0040","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/jnr.24733","article-title":"Noradrenaline protects neurons against H(2) O(2) -induced death by increasing the supply of glutathione from astrocytes via beta(3) -adrenoceptor stimulation","volume":"99","author":"Yoshioka","year":"2021","journal-title":"J Neurosci Res"},{"issue":"4","key":"10.1016\/j.nut.2024.112610_bib0041","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/00001756-199603220-00018","article-title":"Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurones","volume":"7","author":"W\u00fcllner","year":"1996","journal-title":"Neuroreport"},{"issue":"2","key":"10.1016\/j.nut.2024.112610_bib0042","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0304-3940(92)90355-B","article-title":"Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease","volume":"142","author":"Sofic","year":"1992","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.nut.2024.112610_bib0043","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s12640-019-00088-w","article-title":"Carvacrol protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro models of Parkinson's disease","volume":"37","author":"Manouchehrabadi","year":"2020","journal-title":"Neurotox Res"},{"key":"10.1016\/j.nut.2024.112610_bib0044","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.intimp.2018.11.004","article-title":"Neuroprotective effects of Astilbin on MPTP-induced Parkinson's disease mice: Glial reaction, alpha-synuclein expression and oxidative stress","volume":"66","author":"Zhu","year":"2019","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"10.1016\/j.nut.2024.112610_bib0045","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.bbrc.2020.03.097","article-title":"Bruceine D elevates Nrf2 activation to restrain Parkinson's disease in mice through suppressing oxidative stress and inflammatory response","volume":"526","author":"Yang","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.nut.2024.112610_bib0046","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s12640-015-9579-z","article-title":"Glycyrrhizic acid Attenuates Neuroinflammation and Oxidative Stress in Rotenone Model of Parkinson's Disease","volume":"29","author":"Ojha","year":"2016","journal-title":"Neurotox Res"},{"issue":"4","key":"10.1016\/j.nut.2024.112610_bib0047","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.3554","article-title":"Dentate nucleus iron deposition is a potential biomarker for tremor-dominant Parkinson's disease","volume":"30","author":"He","year":"2017","journal-title":"NMR Biomed"},{"issue":"1","key":"10.1016\/j.nut.2024.112610_bib0048","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13024-017-0186-8","article-title":"Post translational changes to alpha-synuclein control iron and dopamine trafficking; a concept for neuron vulnerability in Parkinson's disease","volume":"12","author":"Duce","year":"2017","journal-title":"Mol Neurodegener"},{"issue":"9","key":"10.1016\/j.nut.2024.112610_bib0049","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3109\/10715762.2015.1032958","article-title":"Neuroprotective effects of ginkgetin against neuroinjury in Parkinson's disease model induced by MPTP via chelating iron","volume":"49","author":"Wang","year":"2015","journal-title":"Free Radic Res"},{"issue":"1","key":"10.1016\/j.nut.2024.112610_bib0050","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41598-017-01402-2","article-title":"Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson's disease","volume":"7","author":"Martin-Bastida","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.nut.2024.112610_bib0051","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.neuropharm.2009.09.002","article-title":"Rg1 protects the MPP+-treated MES23.5 cells via attenuating DMT1 up-regulation and cellular iron uptake","volume":"58","author":"Xu","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nut.2024.112610_bib0052","article-title":"EGCG Protects against 6-OHDA-Induced Neurotoxicity in a Cell Culture Model","volume":"2015","author":"Chen","year":"2015","journal-title":"Parkinsons Dis"},{"issue":"3","key":"10.1016\/j.nut.2024.112610_bib0053","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s11481-012-9363-2","article-title":"Neuroprotective effect of curcuminoids against inflammation-mediated dopaminergic neurodegeneration in the MPTP model of Parkinson's disease","volume":"7","author":"Ojha","year":"2012","journal-title":"J Neuroimmune Pharmacol"},{"issue":"10","key":"10.1016\/j.nut.2024.112610_bib0054","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1755-5949.2012.00372.x","article-title":"Fucoidan protects against lipopolysaccharide-induced rat neuronal damage and inhibits the production of proinflammatory mediators in primary microglia","volume":"18","author":"Cui","year":"2012","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"10.1016\/j.nut.2024.112610_bib0055","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12974-017-1036-x","article-title":"Tenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in microglia","volume":"14","author":"Fan","year":"2017","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.nut.2024.112610_bib0056","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jep.2015.01.042","article-title":"Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease","volume":"164","author":"Wang","year":"2015","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"10.1016\/j.nut.2024.112610_bib0057","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00001756-200502280-00013","article-title":"Genistein protects dopaminergic neurons by inhibiting microglial activation","volume":"16","author":"Wang","year":"2005","journal-title":"Neuroreport"},{"key":"10.1016\/j.nut.2024.112610_bib0058","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6527638","article-title":"Triptolide inhibits preformed fibril-induced microglial activation by targeting the MicroRNA155-5p\/SHIP1 pathway","volume":"2019","author":"Feng","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.nut.2024.112610_bib0059","article-title":"Camptothecin regulates microglia polarization and exerts neuroprotective effects via activating AKT\/Nrf2\/HO-1 and inhibiting NF-kappaB pathways in vivo and in vitro","volume":"12","author":"He","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.nut.2024.112610_bib0060","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.intimp.2017.06.007","article-title":"Baicalein exerts anti-neuroinflammatory effects to protect against rotenone-induced brain injury in rats","volume":"50","author":"Zhang","year":"2017","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.nut.2024.112610_bib0061","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s12031-017-1007-9","article-title":"Magnesium lithospermate B suppresses lipopolysaccharide-induced neuroinflammation in BV2 microglial cells and attenuates neurodegeneration in lipopolysaccharide-injected mice","volume":"64","author":"Tai","year":"2018","journal-title":"J Mol Neurosci"},{"issue":"4","key":"10.1016\/j.nut.2024.112610_bib0062","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41401-020-0358-x","article-title":"Rg1 improves LPS-induced Parkinsonian symptoms in mice via inhibition of NF-kappaB signaling and modulation of M1\/M2 polarization","volume":"41","author":"Liu","year":"2020","journal-title":"Acta Pharmacol Sin"},{"issue":"8","key":"10.1016\/j.nut.2024.112610_bib0063","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2174\/1567205017666201111120919","article-title":"Curcumin prevents neuroinflammation by inducing microglia to transform into the M2-phenotype via CaMKKbeta-dependent activation of the AMP-activated protein kinase signal pathway","volume":"17","author":"Qiao","year":"2020","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"10.1016\/j.nut.2024.112610_bib0064","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1080\/01480545.2018.1504961","article-title":"Luteolin protects microglia against rotenone-induced toxicity in a hormetic manner through targeting oxidative stress response, genes associated with Parkinson's disease and inflammatory pathways","volume":"43","author":"Elmazoglu","year":"2020","journal-title":"Drug Chem Toxicol"},{"issue":"9","key":"10.1016\/j.nut.2024.112610_bib0065","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1080\/00207454.2020.1847106","article-title":"Acute parkinsonism in patients with systemic lupus erythematosus: a case report and review of the literature","volume":"132","author":"Wantaneeyawong","year":"2022","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.nut.2024.112610_bib0066","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/bs.pbr.2019.10.006","article-title":"Innate and adaptive immune responses in Parkinson's disease","volume":"252","author":"Schonhoff","year":"2020","journal-title":"Prog Brain Res"},{"issue":"6","key":"10.1016\/j.nut.2024.112610_bib0067","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/jnc.14330","article-title":"Measurements of auto-antibodies to alpha-synuclein in the serum and cerebral spinal fluids of patients with Parkinson's disease","volume":"145","author":"Akhtar","year":"2018","journal-title":"J Neurochem"},{"issue":"4","key":"10.1016\/j.nut.2024.112610_bib0068","first-page":"4883","article-title":"(-)-Epigallocatechin-3-gallate modulates peripheral immunity in the MPTP-induced mouse model of Parkinson's disease","volume":"17","author":"Zhou","year":"2018","journal-title":"Mol Med Rep"},{"issue":"3","key":"10.1016\/j.nut.2024.112610_bib0069","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1600-0404.1994.tb02699.x","article-title":"Parkinson's disease and immunological abnormalities: increase of HLA-DR expression on monocytes in cerebrospinal fluid and of CD45RO+ T cells in peripheral blood","volume":"90","author":"Fiszer","year":"1994","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"10.1016\/j.nut.2024.112610_bib0070","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s11481-019-09888-5","article-title":"Treg cells attenuate neuroinflammation and protect neurons in a mouse model of Parkinson's disease","volume":"15","author":"Huang","year":"2020","journal-title":"J Neuroimmune Pharmacol"},{"issue":"2","key":"10.1016\/j.nut.2024.112610_bib0071","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.intimp.2015.10.032","article-title":"Immunomodulatory and neuroprotective effects of ginsenoside Rg1 in the MPTP(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) -induced mouse model of Parkinson's disease","volume":"29","author":"Zhou","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.nut.2024.112610_bib0072","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3389\/fimmu.2019.00303","article-title":"Autoimmunity in Parkinson's disease: the role of alpha-synuclein-specific T cells","volume":"10","author":"Garretti","year":"2019","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.nut.2024.112610_bib0073","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1471-4159.2008.05697.x","article-title":"Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum","volume":"107","author":"Chen","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.nut.2024.112610_bib0074","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2202-12-116","article-title":"Neuromelanin is an immune stimulator for dendritic cells in vitro","volume":"12","author":"Oberl\u00e4nder","year":"2011","journal-title":"BMC Neurosci"},{"issue":"1","key":"10.1016\/j.nut.2024.112610_bib0075","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-020-00375-7","article-title":"Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders","volume":"15","author":"Machhi","year":"2020","journal-title":"Mol Neurodegener"},{"issue":"10","key":"10.1016\/j.nut.2024.112610_bib0076","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.4049\/jimmunol.1500386","article-title":"Bee venom phospholipase A2, a novel Foxp3+ regulatory T cell inducer, protects dopaminergic neurons by modulating neuroinflammatory responses in a mouse model of Parkinson's disease","volume":"195","author":"Chung","year":"2015","journal-title":"J Immunol"},{"issue":"4587","key":"10.1016\/j.nut.2024.112610_bib0077","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.nut.2024.112610_bib0078","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2021.147434","article-title":"Is there a special relationship between complex I activity and nigral neuronal loss in Parkinson's disease? A critical reappraisal","volume":"1767","author":"Subrahmanian","year":"2021","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.nut.2024.112610_bib0079","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00401-017-1794-7","article-title":"Neuronal complex I deficiency occurs throughout the Parkinson's disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage","volume":"135","author":"Fl\u00f8nes","year":"2018","journal-title":"Acta Neuropathol"},{"issue":"8","key":"10.1016\/j.nut.2024.112610_bib0080","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.tiv.2008.09.007","article-title":"Catalpol protects mesencephalic neurons against MPTP induced neurotoxicity via attenuation of mitochondrial dysfunction and MAO-B activity","volume":"22","author":"Bi","year":"2008","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.nut.2024.112610_bib0081","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6571484","article-title":"Neuroprotective effect of chlorogenic acid on mitochondrial dysfunction-mediated apoptotic death of DA neurons in a Parkinsonian mouse model","volume":"2020","author":"Singh","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.nut.2024.112610_bib0082","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2021.113510","article-title":"Silibinin attenuates motor dysfunction in a mouse model of Parkinson's disease by suppression of oxidative stress and neuroinflammation along with promotion of mitophagy","volume":"239","author":"Liu","year":"2021","journal-title":"Physiol Behav"},{"issue":"1","key":"10.1016\/j.nut.2024.112610_bib0083","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11011-020-00618-y","article-title":"Hesperidin protects against behavioral alterations and loss of dopaminergic neurons in 6-OHDA-lesioned mice: the role of mitochondrial dysfunction and apoptosis","volume":"36","author":"Antunes","year":"2021","journal-title":"Metab Brain Dis"},{"issue":"8","key":"10.1016\/j.nut.2024.112610_bib0084","doi-asserted-by":"crossref","first-page":"11738","DOI":"10.18632\/aging.202868","article-title":"Administration of quercetin improves mitochondria quality control and protects the neurons in 6-OHDA-lesioned Parkinson's disease models","volume":"13","author":"Wang","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.nut.2024.112610_bib0085","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.654340","article-title":"Cannabidiol induces autophagy to protects neural cells from mitochondrial dysfunction by upregulating SIRT1 to inhibits NF-kappaB and NOTCH pathways","volume":"15","author":"Kang","year":"2021","journal-title":"Front Cell Neurosci"},{"issue":"11","key":"10.1016\/j.nut.2024.112610_bib0086","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1177\/0269881114550355","article-title":"Effects of cannabidiol in the treatment of patients with Parkinson's disease: an exploratory double-blind trial","volume":"28","author":"Chagas","year":"2014","journal-title":"J Psychopharmacol"},{"issue":"14","key":"10.1016\/j.nut.2024.112610_bib0087","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1089\/ars.2016.6905","article-title":"Mito-apocynin prevents mitochondrial dysfunction, microglial activation, oxidative damage, and progressive neurodegeneration in mitopark transgenic mice","volume":"27","author":"Langley","year":"2017","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"10.1016\/j.nut.2024.112610_bib0088","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/jnc.14033","article-title":"Molecular mechanisms underlying protective effects of quercetin against mitochondrial dysfunction and progressive dopaminergic neurodegeneration in cell culture and MitoPark transgenic mouse models of Parkinson's Disease","volume":"141","author":"Ay","year":"2017","journal-title":"J Neurochem"},{"issue":"4","key":"10.1016\/j.nut.2024.112610_bib0089","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s12031-013-0222-2","article-title":"Myricitrin alleviates methylglyoxal-induced mitochondrial dysfunction and AGEs\/RAGE\/NF-kappaB pathway activation in SH-SY5Y cells","volume":"53","author":"Wang","year":"2014","journal-title":"J Mol Neurosci"},{"issue":"1","key":"10.1016\/j.nut.2024.112610_bib0090","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tcb.2020.09.008","article-title":"Mitochondrial fusion: the machineries in and out","volume":"31","author":"Gao","year":"2021","journal-title":"Trends Cell Biol"},{"issue":"7844","key":"10.1016\/j.nut.2024.112610_bib0091","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41586-021-03214-x","article-title":"Function and regulation of the divisome for mitochondrial fission","volume":"590","author":"Kraus","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.nut.2024.112610_bib0092","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105433","article-title":"Role of mitophagy in mitochondrial quality control: mechanisms and potential implications for neurodegenerative diseases","volume":"165","author":"Wang","year":"2021","journal-title":"Pharmacol Res"},{"issue":"2","key":"10.1016\/j.nut.2024.112610_bib0093","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/antiox10020248","article-title":"Regulation of mitochondrial dynamics in Parkinson's disease-is 2-methoxyestradiol a missing piece?","volume":"10","author":"Bastian","year":"2021","journal-title":"Antioxidants (Basel)"},{"issue":"3","key":"10.1016\/j.nut.2024.112610_bib0094","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbabio.2020.148157","article-title":"Embelin averts MPTP-induced dysfunction in mitochondrial bioenergetics and biogenesis via activation of SIRT1","volume":"1861","author":"Rao","year":"2020","journal-title":"Biochim Biophys Acta Bioenerg"},{"issue":"7","key":"10.1016\/j.nut.2024.112610_bib0095","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202106046","article-title":"ER-lysosome lipid transfer protein VPS13C\/PARK23 prevents aberrant mtDNA-dependent STING signaling","volume":"221","author":"Hancock-Cerutti","year":"2022","journal-title":"J Cell Biol"},{"issue":"22","key":"10.1016\/j.nut.2024.112610_bib0096","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1002\/1873-3468.14479","article-title":"The ubiquitin-proteasome system and autophagy mutually interact in neurotoxin-induced dopaminergic cell death models of Parkinson's disease","volume":"596","author":"Jang","year":"2022","journal-title":"FEBS Lett"},{"issue":"4","key":"10.1016\/j.nut.2024.112610_bib0097","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s41401-020-0454-y","article-title":"Autophagy-dependent removal of alpha-synuclein: a novel mechanism of GM1 ganglioside neuroprotection against Parkinson's disease","volume":"42","author":"Guo","year":"2021","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"10.1016\/j.nut.2024.112610_bib0098","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/antiox9010037","article-title":"Celastrol inhibits dopaminergic neuronal death of Parkinson's disease through activating mitophagy","volume":"9","author":"Lin","year":"2019","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.nut.2024.112610_bib0099","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152842","article-title":"Natural alkaloid harmine promotes degradation of alpha-synuclein via PKA-mediated ubiquitin-proteasome system activation","volume":"61","author":"Cai","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.nut.2024.112610_bib0100","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3389\/fphar.2018.00377","article-title":"Salidroside promotes the pathological alpha-synuclein clearance through ubiquitin-proteasome system in SH-SY5Y cells","volume":"9","author":"Li","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.nut.2024.112610_bib0101","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bbrc.2022.01.047","article-title":"Alpha-synuclein\/MPP+ mediated activation of NLRP3 inflammasome through microtubule-driven mitochondrial perinuclear transport","volume":"594","author":"Yang","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1016\/j.nut.2024.112610_bib0102","doi-asserted-by":"crossref","first-page":"625","DOI":"10.4196\/kjpp.2017.21.6.625","article-title":"MPTP-induced vulnerability of dopamine neurons in A53T alpha-synuclein overexpressed mice with the potential involvement of DJ-1 downregulation","volume":"21","author":"Lee","year":"2017","journal-title":"Korean J Physiol Pharmacol"},{"issue":"1","key":"10.1016\/j.nut.2024.112610_bib0103","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13041-020-00675-5","article-title":"Endosomal dysfunction in iPSC-derived neural cells from Parkinson's disease patients with VPS35 D620N","volume":"13","author":"Bono","year":"2020","journal-title":"Mol Brain"},{"issue":"8","key":"10.1016\/j.nut.2024.112610_bib0104","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/10286020.2017.1339349","article-title":"Neuroprotective effect of alpha-mangostin on mitochondrial dysfunction and alpha-synuclein aggregation in rotenone-induced model of Parkinson's disease in differentiated SH-SY5Y cells","volume":"19","author":"Hao","year":"2017","journal-title":"J Asian Nat Prod Res"},{"issue":"12","key":"10.1016\/j.nut.2024.112610_bib0105","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1093\/brain\/awac313","article-title":"DJ-1 is an essential downstream mediator in PINK1\/parkin-dependent mitophagy","volume":"145","author":"Imberechts","year":"2022","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.nut.2024.112610_bib0106","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s10571-020-00914-2","article-title":"An E3 ubiquitin ligase, plays an essential role in mitochondrial quality control in Parkinson's disease","volume":"41","author":"Wang","year":"2021","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.nut.2024.112610_bib0107","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104717","article-title":"Loss of Parkin contributes to mitochondrial turnover and dopaminergic neuronal loss in aged mice","volume":"136","author":"Noda","year":"2020","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10.1016\/j.nut.2024.112610_bib0108","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12017-019-08562-6","article-title":"Alpha-arbutin protects against Parkinson's disease-associated mitochondrial dysfunction in vitro and in vivo","volume":"22","author":"Ding","year":"2020","journal-title":"Neuromolecular Med"},{"issue":"14","key":"10.1016\/j.nut.2024.112610_bib0109","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1002\/mds.22156","article-title":"Mutation analysis of Parkin, PINK1, DJ-1 and ATP13A2 genes in Chinese patients with autosomal recessive early-onset Parkinsonism","volume":"23","author":"Guo","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.nut.2024.112610_bib0110","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.freeradbiomed.2020.12.004","article-title":"Fidelity of the PINK1 knockout rat to oxidative stress and other characteristics of Parkinson disease","volume":"163","author":"Ren","year":"2021","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.nut.2024.112610_bib0111","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1038\/s41467-022-30178-x","article-title":"Pantothenate kinase 2 interacts with PINK1 to regulate mitochondrial quality control via acetyl-CoA metabolism","volume":"13","author":"Huang","year":"2022","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.nut.2024.112610_bib0112","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1007\/s12035-016-9843-0","article-title":"Curcumin rescues a PINK1 knock down SH-SY5Y cellular model of Parkinson's disease from mitochondrial dysfunction and cell death","volume":"54","author":"van der Merwe","year":"2017","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.nut.2024.112610_bib0113","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2022.107300","article-title":"Evaluation of curcumin as add-on therapy in patients with Parkinson's disease: a pilot randomized, triple-blind, placebo-controlled trial","volume":"218","author":"Ghodsi","year":"2022","journal-title":"Clin Neurol Neurosurg"},{"issue":"28","key":"10.1016\/j.nut.2024.112610_bib0114","doi-asserted-by":"crossref","first-page":"7977","DOI":"10.1007\/s00216-022-04341-8","article-title":"Altered prefrontal neurochemistry in the DJ-1 knockout mouse model of Parkinson's disease: complementary semi-quantitative analyses with in vivo magnetic resonance spectroscopy and MALDI-MSI","volume":"414","author":"Chen","year":"2022","journal-title":"Anal Bioanal Chem"},{"issue":"6","key":"10.1016\/j.nut.2024.112610_bib0115","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1134\/S000629792106002X","article-title":"DJ-1 protein and its role in the development of Parkinson's disease: studies on experimental models","volume":"86","author":"Buneeva","year":"2021","journal-title":"Biochemistry (Mosc)"},{"issue":"50","key":"10.1016\/j.nut.2024.112610_bib0116","doi-asserted-by":"crossref","first-page":"25322","DOI":"10.1073\/pnas.1906565116","article-title":"DJ-1 regulates the integrity and function of ER-mitochondria association through interaction with IP3R3-Grp75-VDAC1","volume":"116","author":"Liu","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.nut.2024.112610_bib0117","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.bbrc.2015.01.060","article-title":"Myricitrin alleviates MPP+-induced mitochondrial dysfunction in a DJ-1-dependent manner in SN4741 cells","volume":"458","author":"Cai","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"10.1016\/j.nut.2024.112610_bib0118","doi-asserted-by":"crossref","first-page":"14726","DOI":"10.3390\/molecules181214726","article-title":"Baicalein prevents 6-hydroxydopamine-induced mitochondrial dysfunction in SH-SY5Y cells via inhibition of mitochondrial oxidation and up-regulation of DJ-1 protein expression","volume":"18","author":"Wang","year":"2013","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.nut.2024.112610_bib0119","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1042\/BST20160228","article-title":"Cellular functions of LRRK2 implicate vesicular trafficking pathways in Parkinson's disease","volume":"44","author":"Cookson","year":"2016","journal-title":"Biochem Soc Trans"},{"issue":"5","key":"10.1016\/j.nut.2024.112610_bib0120","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/mds.28927","article-title":"Differential Phospho-Signatures in Blood Cells Identify LRRK2 G2019S Carriers in Parkinson's Disease","volume":"37","author":"Garrido","year":"2022","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.nut.2024.112610_bib0121","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/19768354.2021.1883735","article-title":"Analysis of alpha-synuclein levels related to LRRK2 kinase activity: from substantia nigra to urine of patients with Parkinson's disease","volume":"25","author":"Nam","year":"2021","journal-title":"Anim Cells Syst (Seoul)"},{"key":"10.1016\/j.nut.2024.112610_bib0122","doi-asserted-by":"crossref","first-page":"e67604","DOI":"10.7554\/eLife.67604","article-title":"Pharmacological rescue of impaired mitophagy in Parkinson's disease-related LRRK2 G2019S knock-in mice","volume":"10","author":"Singh","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.nut.2024.112610_bib0123","article-title":"Curcumin pre-treatment may protect against mitochondrial damage in LRRK2-mutant Parkinson's disease and healthy control fibroblasts","volume":"27","author":"Abrahams","year":"2021","journal-title":"Biochem Biophys Rep"}],"container-title":["Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899900724002594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899900724002594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T14:43:05Z","timestamp":1733841785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899900724002594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":123,"alternative-id":["S0899900724002594"],"URL":"https:\/\/doi.org\/10.1016\/j.nut.2024.112610","relation":{},"ISSN":["0899-9007"],"issn-type":[{"value":"0899-9007","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plant-derived compounds as potential neuroprotective agents in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nut.2024.112610","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112610"}}